Abidova S S, Ovchinnikov I V, Gimmel'farb G N
Eksp Klin Farmakol. 1994 Nov-Dec;57(6):42-4.
The intraperitoneal administration of ketalar in a dose of 50 mg/kg elevated the myocardial levels of triglycerides, reduced non-esterified fatty acids and enhanced uncontrolled mitochondrial respiration during oxidation of caprylate and palmitoylcarnitine. The efficiency of phosphorylation remained unchanged.
腹腔注射剂量为50毫克/千克的氯胺酮,可提高心肌甘油三酯水平,降低非酯化脂肪酸水平,并增强辛酸和棕榈酰肉碱氧化过程中不受控制的线粒体呼吸。磷酸化效率保持不变。